brello semaglutide reddit The Department of Veterans Affairs on Thursday announced a clinical trial to test whether injectable semaglutide, a GLP-1 drug widely prescribed for diabetes and weight loss can also treat alcohol abuse, a Penn researchers published a study

Serial InBody assessments reveal adaptation through: Falling BMR despite maintained or reduced weight Muscle loss with simultaneous fat regain after stopping therapy Slower weight loss plateau despite continued medication Declining phase angle indicates cellular health deterioration Tracking these trends is essential for understanding why weight regain is common after stopping GLP-1 therapy and why concurrent muscle preservation strategies are non-negotiable in any complete semaglutide management programme

Wilmore DW, Shabert JK

Some researchers have explored concurrent use of different GLP-1 agents , though this is less established in clinical practice

Protein intake becomes critical from day one